Early Alzheimer's Disease - Wake Research

Early Alzheimer’s Disease

pictured: an elderly woman smiles up at a caregiver

When It Comes to Alzheimer’s, It Helps to Have a Team  

The goal of this clinical trial to evaluate the effectiveness and safety of a new treatment in participants diagnosed with Early Alzheimer’s Disease.

Participant Requirement:

  • Participants must have been diagnosed with Early Alzheimer’s Disease.

*Other requirement may apply

Get Pre-Qualified
pictured: an elderly woman smiles up at a caregiver

Why Participate?

Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.

Experience

The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.

Safety

Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.

Pharmacology Research Institute - Los Alamitos

Main Office
+1-714-827-3667

Our Hours
Mon: 8AM – 5PM
Tues: 8AM – 5PM
Wed: 8AM – 5PM
Thurs: 8AM – 5PM
Fri: 8AM – 2PM

Location
4281 Katella Avenue, Suite 230
Los Alamitos, CA 90720